Journal Mobile Options
Table of Contents
Vol. 78, No. 3, 2009
Issue release date: April 2009
Psychother Psychosom 2009;78:152–160

Inpatient versus Day Clinic Treatment for Bulimia Nervosa: A Randomized Trial

Zeeck A. · Weber S. · Sandholz A. · Wetzler-Burmeister E. · Wirsching M. · Hartmann A.
Department of Psychosomatic Medicine and Psychotherapy, University of Freiburg, Freiburg, Germany

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background: In bulimia nervosa, more intense treatments are recommended if outpatient treatment fails. This is the first randomized controlled trial comparing the options of inpatient versus day clinic treatment. Method: Patients with severe bulimia nervosa were randomly assigned to inpatient or day clinic treatment of similar length and intensity. Specific and general psychopathology was assessed at the end of treatment and a 3-month follow-up. Results: Fifty-five patients were randomized; 22 day clinic patients and 21 inpatients started the program. At the end of treatment, a significant reduction of general and specific pathology was found in both settings. Following discharge, there was more deterioration in bulimic symptoms after inpatient treatment, but overall, results were comparable. Conclusions: Inpatient and day clinic programs are effective treatments for severely disturbed bulimic patients with similar results at the 3-month follow-up. Further follow-up will show if a higher instability of results after inpatient treatment is of importance in the long term.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Rosenvinge J, Martinussen M, Ostensen E: The comorbidity of eating disorders and personality disorders: a meta-analytic review of studies published between 1983 and 1998. Eat Weight Disord 2000;5:52–61.
  2. Milos G, Spindler A, Buddeberg C, Crameri A: Axes I and II comorbidity and treatment experiences in eating disorder subjects. Psychother Psychosom 2003;72:276–285.
  3. Keel P, Dorer D, Eddy K, Delinsky S, Franko D, Blais M, Keller M, Herzog DB: Predictors of treatment utilization among women with anorexia and bulimia nervosa. Am J Psychiatry 2002;159:140–142.
  4. National Institute of Clinical Excellence: Eating Disorders: National Clinical Practice Guideline No. CG6. London, The British Psychological Society and The Royal College of Psychiatrists, 2004.
  5. Shapiro J, Berkman N, Brownley K, Sedway J, Lohr K, Bulik C: Bulimia nervosa treatment: a systematic review of randomized controlled trials. Int J Eat Disord 2007;40:321–336.
  6. Ricca V, Mannucci E, Zucchi T, Rotella C, Faravelli C: Cognitive-behavioural therapy for bulimia nervosa and binge eating disorder. Psychother Psychosom 2000;69:287–295.
  7. Fairburn C: A cognitive-behavioural approach to the treatment of bulimia. Psychol Med 1981;11:707–711.
  8. Fairburn C, Jones R, Peveler R, Carr S, Soloman R, O´Connor M, Burton J, Hope R: Three psychological treatments for bulimia nervosa: a comparative trial. Arch Gen Psychiatry 1991;48:463–469.
  9. American Psychiatric Association: Practice Guideline for the Treatment of Patients with Eating Disorders (Revision). New York, American Psychiatric Association, 2006.
  10. Kaplan A, Olmsted M: Partial hospitalization; in Garner D, Garfinkel P (eds): Handbook of Treatment for Eating Disorders, ed 2. New York, The Guilford Press, 1997, pp 354–360.
  11. Zeeck A, Herzog T, Hartmann A: Day clinic or inpatient care for severe bulimia nervosa? Eur Eat Disord Rev 2004;12:79–86.

    External Resources

  12. Ro O, Martinsen E, Hoffart A, Rosenvinge J: Short-term follow-up of severe bulimia nervosa after inpatient treatment. Eur Eat Disord Rev 2003;11:405–417.

    External Resources

  13. Kächele H, Kordy H, Richard M, Research Group TR-EAT: Therapy amount and outcome of inpatient psychodynamic treatment of eating disorders in Germany: data from a multicenter study. Psychother Res 2001;11:239–257.
  14. Fichter M, Quadflieg N: Six-year course of bulimia nervosa. Int J Eat Disord 1997;22:361–384.
  15. Zeeck A, Sandholz A, Hipp W, Schmidt A: Stationäre und teilstationäre Bulimietherapie – Das Freiburger Konzept. Psychotherapeut 2005;50:43–51.

    External Resources

  16. Walpoth M, Hoertnagl C, Mangweth-Matzek B, Kemmler G, Hinterhölzl J, Conca A, Hausman A: Repetitive transcranial magnetic stimulation in bulimia nervosa: preliminary results of a single-centre, randomized, double-blind, sham-controlled trial in female outpatients. Psychother Psychosom 2008;77:57–60.
  17. Garner, D: Eating Disorder Intentory-2. Professional manual. Odessa, Psychological Assessment Resources, 1991.
  18. Meermann R, Napierski C, Schulenkorf E: EDI-Münster: Selbstbeurteilungsfragebogen für Essstörungen; in Meermann R, Vandereycken W (eds): Therapie der Magersucht und Bulimia nervosa: Ein klinischer Leitfaden für den Praktiker. Berlin, De Gruyter, 1987.
  19. Fichter M, Quadflieg N: The structured interview for anorexic and bulimic disorders for DSM IV and ICD-10 (SIAB-EX). Eur Psychiatry 2001;16:38–48.
  20. Derogatis L: SCL-90-R, Administration, Scoring and Procedures Manual-I for the R(evised) Version. Baltimore, Johns Hopkins University School of Medicine, 1977.
  21. Franke G: Die Symptom-Checkliste von Derogatis (SCL-90-R) – Deutsche Version – Manual. Weinheim, Beltz Test, 2002.
  22. Wittchen H-U, Zaudig M, Fydrich T: SKID Strukturiertes klinisches Interview für DSM IV (Achse I + II). Göttingen, Hogrefe-Verlag, 1997.
  23. Jacobson N, Truax P: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991;59:12–19.
  24. Hartmann A, Zeeck A, van der Koij: Severity of bulimia nervosa – components of the syndrome and definition of therapy outcome. Psychopathology, in press.
  25. Fairburn C, Cooper Z, Doll H, Norman P, O’Connor M: The natural course of bulimia nervosa and binge eating disorder in young women. Arch Gen Psychiatry 2000;57:659–665.
  26. Zeeck A, Herzog T, Kuhn K, Hartmann A, Scheidt C, Wirsching M: Teilstationäre Psychotherapie. Psychother Med Psychol 2002;52:1–8.

    External Resources

  27. Steiger H, Stotland S: Prospective study of outcome in bulimics as a function of axis-II comorbidity: long term responses on eating and psychiatric symptoms. Int J Eat Disord 1996;20:149–161.
  28. Quadflieg N, Fichter M: The course and outcome of bulimia nervosa. Eur Child Adolesc Psychiat 2003;12(suppl 1):99–109.
  29. Clausen L: Review of studies evaluating psychotherapy in bulimia nervosa: the influence of research methods. Scand J Psychol 2004;45:247–252.
  30. Olmsted M, Kaplan A, Rockert W: Defining remission and relapse in bulimia nervosa. Int J Eat Disord 2005;38:1–6.
  31. Vaz F: Outcome of bulimia nervosa: prognostic indicators. J Psychosom Res 1998;45:391–400.
  32. Micali N, Holliday J, Karwautz A, Haidvogel M, Wagner G, Fernandez-Aranda F, Badia A, Gimenez L, Solano R, Brecelj-Anderluh M, Mohan R, Collier D, Treasure J: Childhood eating and weight in eating disorders: a multi-centre European study of affected women and their unaffected sisters. Psychother Psychosom 2007;76:234–241.
  33. Fairburn C: Prediction of outcome in bulimia nervosa. Am J Psychiatry 2004;161:2322–2324.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50